Jon J. Tanja,RPh,Ms,Fascp;Theresa M. Langlass,RPh,PharmD

Widen E. , Eriksson JG , Groop LC Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM. Diabetes 1992;41:354-58.

Bailey CJ Biguanides and NIDDM. Diabetes Care 1992;15(6):755-72.

Miller RR , Greenblatt DJ Handbook of drug therapy. New York: Elsevier, 1979:685-92.

Hermann LS Biguanides and sulfonylureas as combination therapy in NIDDM. Diabetes Care. 1990;13(suppl3):37-41.

Hermann LS , Karlsson JE , Sjostrand A. Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles. Eur J Clin Pharmacol 1991;41:263-65.

Groop LC Sulfonylureas in NIDDM. Diabetes Care 1992 ;15(6):737-54.

Stout RW , Brunzell JD , Bierman EL , Porte D. Effect of phenformin on glucose-insulin interrelationships. Diabetes 1974;23:624-30.

Traub SL , ed. Basic skills in interpreting laboratory data. Bethesda, Md: ASHP,1992:233.

Wu MS , Johnston P. , Sheu Whh , et al. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care 1991;13(1):1-8.

DeFronzo RA , Barzilai N. , Simonson DC Mechanism of metformin action in obese and lean non-insulin-dependent diabetic subjects. J Clin EndocrinolMetab 1991;73:1294-1301.

Dorman TL , Heller SR , Peck GM , Tattersall RB Double-blind evaluation of efficacy and tolerability of metformin in NIDDM . Diabetes Care 1991;14(4):342-43.

Perriello G. , Misericordia P. , Volpi E. , et al. Acute antihyperglycemic mechanisms of metformin in NIDDM. Diabetes 1994;43:920-82.

Sum CF , Webster JM , Johnson AB , Catalano C. , Cooper BG , Taylor R. The effect of intravenous metformin on glucose metabolism during hyperglycaemia in type II diabetes. Diabetic Med 1992;9:61-65.

Benzi L. , Trischitta V. , Ciccarone A. , et al. Improvement with metformin in insulin intemalization and processing in monocytes from NIDDM patients. Diabetes 1990;39:844-49.

Janssen M. , Rillaerts E. , De Leeuw I. Effects of metformin on haemorheology, lipid parameters and insulin resistance in insulin-dependent diabetic patients (IDDM). Biomed Pharmacother 1991;45: 363-67.

Pentikainen PJ , Voutilainen E. , Aro An , Uusitupa M. , Penttila I. , Vapaatalo H. Cholesterol lowering effect of metformin in combined hyperlipidemia: placebo controlled double blind trial. Ann Med 1990;22:307-12:

Khan IH , Catto Grd , MacLeod AM. Severe lactic acidosis in patient receiving continuous ambulatory peritoneal dialysis. Br Med J 1993 ;307: 1056-57.

Gan SC , Barr J. , Arieff AI , Pearl RG Biguanide-associated lactic acidosis. Arch Intern Med 1992;152:2333-36.

Olin BR , Hebel SK , Dombek CE , Kastrup EK , eds. Drug facts & comparisons . St. Louis: Facts & Comparison, Inc,1994:762.

McIntyre HD , Ma A. , Bird DM , Paterson CA , Ravenscroft PJ , Cameron DP Metformin increases insulin sensitivity and basal glucose clearance in type 2 (non-insulin-dependent) diabetes mellitus . AustNZJMed 1991;21:714-19.

Reaven GM , Johnston P. , Hollenbecle CB , et al. Combined metformin-sulfonylurea treatment of patients with non-insulin-dependent diabetes in fair to poor glycemic control. J Clin Endocnhol Metab 1002;74:1020-26.

Lamey PJ , Gibson J. , Barclay SC , Miller S. Grinspan's syndrome: a drug-induced phenomenon? Oral Surg Oral Med Oral Path 1990;70: 184-85.

Jeppesen J. , Zhou MY , Chen Ydi , Reaven GM Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM. Diabetes Care 1994;17(10):1093-99.

Hermann LS , Schersten B. , Bitzen PO , Kjellstrom T. , Lindgarde F. , Melander A. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. Diabetes Care 1994;17(10):1100-9.